Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

Max-Planck-Institut für Molekulare Zellbiologie und Genetik

TDS - Screening Facility

HT – Technology Development Studio (TDS), the Screening Facility of the MPI-CBG At the ‘High-Throughput Technology Development Studio’ (TDS), the Screening Facility of the ‘Max Planck Institute of Molecular Cell Biology and Genetics’ (MPI-CBG) in Dresden, we are developing phenotypic assays and implementing high-content screens in cultured cells and model organisms with the aid of robotic systems and automated microscopy to discover novel gene functions and small molecule compounds in close collaboration with internal and external scientific groups. Through partnerships with Evotec Technologies GmbH and Definiens AG we are leaders in automated microscopy and software development for pattern recognition and image analysis. In close collaborations with Cenix BioScience GmbH and academic partners we are tightly involved in RNA interference technology development and RNAi libraries generation. The final goal is to set-up high-throughput high-content screens based on automated microscopy and image analysis, and to integrate screens with other post-genomics discovery technologies such as expression profiling and TILLING (Targeting Induced Local Lesions In Genomes).

Details


Adresse:
Max-Planck-Institut für Molekulare Zellbiologie und Genetik
TDS - Screening Facility
Pfotenhauerstr.108
01307 Dresden
Deutschland
Arbeitsgebiet:
Forschung & Entwicklung
Expansion:
national
Webseite:
Mitarbeiteranzahl:
51-500
Gründungsjahr:
1998